
Keywords: BZD; benzodiazepine; FDA; Food and Drug Administration; CCI; Charlson comorbidity index; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; NHIA; National Health Insurance Administration; NHIRD; National Health Insu